Published in Arch Dermatol on May 01, 1993
It takes two to tango: mast cell and Schwann cell interactions in neurofibromas. J Clin Invest (2003) 0.95
The plexiform neurofibroma microenvironment. Cancer Microenviron (2012) 0.95
The new deal: a potential role for secreted vesicles in innate immunity and tumor progression. Front Immunol (2015) 0.93
Pathogenesis of plexiform neurofibroma: tumor-stromal/hematopoietic interactions in tumor progression. Annu Rev Pathol (2011) 0.91
Pruritus: management algorithms and experimental therapies. Semin Cutan Med Surg (2011) 0.90
Mast cells can contribute to axon-glial dissociation and fibrosis in peripheral nerve. Neuron Glia Biol (2007) 0.88
Optimizing biologically targeted clinical trials for neurofibromatosis. Expert Opin Investig Drugs (2013) 0.88
Achieving consensus for clinical trials: the REiNS International Collaboration. Neurology (2013) 0.82
Different patterns of mast cells distinguish diffuse from encapsulated neurofibromas in patients with neurofibromatosis 1. J Histochem Cytochem (2011) 0.81
Drug therapy for neurofibromatosis? Arch Dermatol (1993) 0.77
Evaluating the Anti-nociceptive and Anti-inflammatory Effects of Ketotifen and Fexofenadine in Rats. Adv Pharm Bull (2015) 0.75
The role of the immune system in neurofibromatosis type 1-associated nervous system tumors. CNS Oncol (2016) 0.75